about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerDerangements in bone mineral parameters and bone mineral density in south Indian subjects on antiepileptic medicationsDiabetes mellitus and electrolyte disorders.Approach to the hypophosphatemic patientParameters of Calcium Metabolism Fluctuated during Initiation or Changing of Antipsychotic Drugs.Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report.Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy.Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemiaRefeeding syndrome or refeeding hypophosphatemia: a systematic review of cases.Optimal use of phosphate binders in chronic kidney disease.Phosphorus and calcium: a review for the adult nutrition support clinician.Raine Syndrome (OMIM #259775), Caused By FAM20C Mutation, Is Congenital Sclerosing Osteomalacia With Cerebral Calcification (OMIM 259660).Acid-base and electrolyte disorders associated with the use of antidiabetic drugs.Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia.Phosphate imbalance in patients with heart failure.A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration.Life-threatening hypophosphataemia in a cirrhotic patient with jaundiceOn the effect of the injection of potassium phosphate in vivo inducing the precipitation of serum calcium with inorganic phosphate.Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma.Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.Recurrent persistent hypophosphatemia in a male-to-female transgender patient with anorexia nervosa: Case report.Impact of Early Versus Late Diuretic Exposure on Metabolic Bone Disease and Growth in Premature Neonates.Acute Phosphate Restriction Impairs Bone Formation and Increases Marrow Adipose Tissue in Growing Mice.Bone resorption: supporting immunometabolism.Serum phosphate and phosphate-regulatory hormones in COPD patientsYield of diagnostic tests in unexplained renal hypophosphatemia: a case series
P2860
Q24197545-BE699F71-FE4C-4F6B-94F2-F32EDBDCE64FQ34169824-2C39A65F-6F9A-4E95-A8A5-C489BE6992ADQ34344884-F402EBE3-FCB0-4195-927D-95E95F5288F7Q35869678-F2D659AB-0FCD-4BE4-A425-93AF2AF71FA5Q36431173-706518B2-EFF8-4BDD-80AA-2AB7B2D88543Q36433566-A3E93CF3-EC9E-440B-ABE3-DDB1591A1711Q36882557-907B43A2-1371-48B7-A467-945884389C5DQ37256840-19A9A50B-5B39-44C1-9332-69EEB55A7004Q37629734-E95649C8-ABAC-4D20-95E4-E23ECCE2DC83Q37981600-543E9234-F874-4D31-A513-292D08B0BA64Q38161580-3E02D2B7-5331-4A1C-9874-CDCC34747779Q38304345-613356B8-E5B1-4FF8-8D80-92E9A9D09B86Q38377280-A40C38A7-2EA4-43BB-9AC1-A49072005153Q38658251-627EBFC3-3FE0-45EE-8588-6383D537AA9AQ39214226-0A26B023-1755-4E10-8B64-0CD42B110873Q39255830-B399BB8F-5C83-4EDC-9E1B-D717C4F401DFQ40135167-67FF5C47-0ECD-4AF8-81E5-F885ADC691E5Q40416673-DC13C982-A3ED-4053-B28D-66048AA42D06Q41817713-8D90B268-7641-453B-804F-05B2F036B01AQ42369414-51D6ACB4-0FAD-4158-8287-E6A656D6912AQ42369658-BFB9842F-456D-4BC2-97D8-7749ABCD54E8Q47806351-AEAEA7C9-1A01-414D-BB06-8DB39363C4D1Q50335307-D8A04F4B-6FCE-4B4C-8EB1-39EEB4D597D0Q51692271-47773F16-8D0F-49E6-AE2C-C3E7A66C6F9CQ53701668-17B61D6F-0424-4F26-8FF2-CB9F8A987118Q58711341-97CE903B-26C7-456B-B3A7-902C1B2C8794Q58765191-2091709C-86BE-492D-A79B-179C4C3F6365
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medication-induced hypophosphatemia: a review.
@en
Medication-induced hypophosphatemia: a review.
@nl
type
label
Medication-induced hypophosphatemia: a review.
@en
Medication-induced hypophosphatemia: a review.
@nl
prefLabel
Medication-induced hypophosphatemia: a review.
@en
Medication-induced hypophosphatemia: a review.
@nl
P2093
P2860
P356
P1476
Medication-induced hypophosphatemia: a review.
@en
P2093
P2860
P304
P356
10.1093/QJMED/HCQ039
P407
P577
2010-03-30T00:00:00Z